Episode 64 - Psychedelics

Breaking Bad Science

We’d love to hear from you ([e-mail])

Look us up on social media

Facebook: https://www.facebook.com/groups/385282925919540

Instagram: https://www.instagram.com/breakingbadsciencepodcast/

Website: http://www.breakingbadscience.com/

Patreon: https://www.patreon.com/breakingbadscience

What do Ted Kaczynski, Bono's character in the movie Across the Universe, and the inventor of one of the most important technological advancements of our time have in common? In a word, Psychedelics. In most of these cases it’s specifically lysergic acid diethylamide, colloquially known as LSD. Join hosts Shanti and Danny as we discuss, what psychedelics are, how the UN fits into the conversation, and if there is more than we were taught in the D.A.R.E program in the 90's?

References

1. Carlson, P.; Nobel Chemist Kary Mullis, Making Waves as a Mind Surfer. Washington Post. 03-Nov-1998. https://www.washingtonpost.com/archive/lifestyle/1998/11/03/nobel-chemist-kary-mullis-making-waves-as-a-mind-surfer/31e7e720-44e4-49ff-8458-a9822cdcb47e/
2. The Economic and Social Council of the United Nations; Final Act of the United Nations Conference for the Adoption of a Protocol on Psychotropic Substances. UN Convention 1971. 21-Feb-1971. https://www.unodc.org/pdf/convention_1971_en.pdf
3. Byock, I.; Taking Psychedelics Seriously. Journal of Palliative Medicine. 01-Apr-2018. 21:4 (417 - 421). Doi: https://doi.org/10.1089/jpm.2017.0684
4. Brodwin, E.; The Truth About ‘Microdosing,’ Which Involves Taking Tiny Amounts of Psychedelics Like LSD. Business Insider. 30-Jan-2017. https://www.businessinsider.com/microdosing-lsd-effects-risks-2017-1
5. Vardy, M., Kay, S.; LSD Psychosis or LSD-Induced Schizophrenia? A Multimethod Inquiry. Archives of General Psychiatry. Aug-1983. 40:8 (877 - 883). Doi: https://doi.org/10.1001/archpsyc.1983.01790070067008
6. Cheung, T.; Compass Pathways Receives FDA Breakthrough Therapy Designation for Psilocybin Therapy for Treatment-Resistant Depression. 23-Oct-2018. US Food and Drug Administration. https://compasspathways.com/compass-pathways-receives-fda-breakthrough-therapy-designation-for-psilocybin-therapy-for-treatment-resistant-depression/

Support the show